Found: 1
Select item for more details and to access through your institution.
EZH2 Inhibition Compromises α4-1BB-Mediated Antitumor Efficacy by Reducing the Survival and Effector Programming of CD8<sup>+</sup> T Cells.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.770080
- By:
- Publication type:
- Article